Cigna Corp (CI)
$190.50
2.85 (1.52%)
CI Stock Quote Delayed 30 Minutes
Previous Close
$190.50
Market Cap
46.34B
PE Ratio
18.69
EPS
10.19
Volume (Avg. Vol.)
2.00M
Day's Range
187.48 - 192.35
52-Week Range
118.50 - 224.64
Dividend & Yield
0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
Cigna’s Merger With Express Scripts Is Positive for Cigna Stock
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
What Cigna Investors Should Expect From Its Latest Victory
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
Trade of the Day: Express Scripts (ESRX)
Express Scripts (NASDAQ:ESRX), a pharmacy benefit management company operating in the United States and Canada, reported its latest earnings this past Wednesday, Aug. 1, and the stock moved sharply lower when the report crossed the tape.
3 Big Stock Charts for Thursday: Albemarle, Realty Income and CIGNA
The stock charts of CIGNA, Albemarle and Realty Income offer the best reliable technical reads here.
Trade of the Day: Citigroup Flags a Bullish Reversal
Citigroup recently reported earnings and it has since firmly planted a bullish reversal on its charts. This sets up bullish near-term trading opportunities in C stock.
5 GARP Stocks for a Winning Portfolio
If you’re looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GAR....
Cigna Corporation Stock Is Trading at a Steep Discount
CI stock is trading at over 20% below its yearly high, and it's discounted ahead of the Express Scripts deal. Investors will want to consider Cigna's long-term upside when the deal closes.
Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck
Cigna Corporation stock has had an ugly 2018 so far. And given the wait ahead of its Express Scripts acquisition, the Q1 earnings beat is unlikely to change the trend for CI stock.
The 7 Most Undervalued Stocks In Larry Robbins’ Portfolio
Larry Robbins is a well-known GARP investor. Here are some of his hedge fund's -- Glenview Capital Management -- most undervalued stocks.
The Reviews for the Cigna Corporation-ExpressScripts Deal Are In…And Bad
Analysts are skeptical that buying the largest Pharmacy Benefit Manager will help make Cigna -- one of the smaller health insurers -- more profitable.
Cigna Corporation Is Too Late to the Party
Cigna is paying more than its own market cap for ExpressScripts, the largest Pharmacy Benefit Manager.
Stocks Continue to Waver as Trump Unveils Tariffs
Stocks finished mixed on Thursday as President Trump finally unveiled the steel and aluminum tariffs that were hinted at last week.
Express Scripts Holding Co Stock Soars on Cigna Corporation Deal
Express Scripts (ESRX) stock was on the rise Thursday following news of a deal with Cigna (CI) that will have the two companies merging together.
What Remains For Rite Aid Corporation? The Risks of Going It Alone
Rite Aid bulls hope it finds a buyer, while bears see it circling the drain. RAD stock might be fun to trade right now, but watch it closely.
Exceptional Quant Score Keeps Cigna (CI) a Strong Buy
The current recommendation of Strong Buy for Cigna Corporation (NYSE:CI) is computed using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. CI has maintained this ranking for 4 months.
Cigna (CI) a Strong Buy on Exceptional Earnings Momentum
Cigna Corporation (NYSE:CI) is one of the 782 companies in the GICS Health Care sector, and a member of the 82 company Health Care Providers & Services GICS industry group within this sector. The market value of CI is $51.6 billion which places it in the top decile in its industry group. The stock's current Portfolio Grader score places it 3 among the 82 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 15 among the 782 companies in the sector, and number 98 in the nearly 5,000 company Portfolio Grader universe.
Stellar Measures for Earnings Growth Make Cigna (CI) a Strong Buy
Cigna Corporation (NYSE:CI) is a member of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of CI is $49.6 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 3 among the 82 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 16 among the 781 companies in the sector, and number 97 in the nearly 5,000 company Portfolio Grader universe.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
